A polymorphism in the angiogenesis inhibitor, endostatin, in lung cancer susceptibility

Lung Cancer. 2008 Feb;59(2):276-8. doi: 10.1016/j.lungcan.2007.10.018. Epub 2007 Dec 4.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Biomarkers, Tumor / genetics*
  • Biomarkers, Tumor / metabolism
  • DNA, Neoplasm / genetics*
  • Endostatins / genetics*
  • Endostatins / metabolism
  • Female
  • Genetic Predisposition to Disease*
  • Genotype
  • Humans
  • Lung Neoplasms* / blood supply
  • Lung Neoplasms* / genetics
  • Lung Neoplasms* / metabolism
  • Male
  • Mice
  • Mice, Nude
  • Middle Aged
  • Neoplasms, Experimental / blood supply
  • Neoplasms, Experimental / genetics
  • Neoplasms, Experimental / metabolism
  • Neovascularization, Pathologic / genetics*
  • Polymorphism, Genetic*
  • Prognosis

Substances

  • Biomarkers, Tumor
  • DNA, Neoplasm
  • Endostatins